NCT06532253: Long-term Safety Trial with NVDX3
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 15 planned
- Started
- 22 Aug 2024
- Primary completion
- Mar 2036
- Arms
- NVDX3 implant
- Results
- None posted
- 1 Aug 2024: Trial registered
- 22 Aug 2024: Trial started
A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.
Kind of treatment: Drug.
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.